[go: up one dir, main page]

AU2003265170A1 - 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists - Google Patents

2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists

Info

Publication number
AU2003265170A1
AU2003265170A1 AU2003265170A AU2003265170A AU2003265170A1 AU 2003265170 A1 AU2003265170 A1 AU 2003265170A1 AU 2003265170 A AU2003265170 A AU 2003265170A AU 2003265170 A AU2003265170 A AU 2003265170A AU 2003265170 A1 AU2003265170 A1 AU 2003265170A1
Authority
AU
Australia
Prior art keywords
adenosine
receptor antagonists
aminopyrimidine derivatives
aminopyrimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003265170A
Inventor
Atsushi Akahane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2002950853A external-priority patent/AU2002950853A0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AU2003265170A priority Critical patent/AU2003265170A1/en
Publication of AU2003265170A1 publication Critical patent/AU2003265170A1/en
Abandoned legal-status Critical Current

Links

AU2003265170A 2002-08-19 2003-08-14 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists Abandoned AU2003265170A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003265170A AU2003265170A1 (en) 2002-08-19 2003-08-14 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2002950853 2002-08-19
AU2002950853A AU2002950853A0 (en) 2002-08-19 2002-08-19 Aminopyrimidine compound and pharmaceutical use thereof
PCT/JP2003/010360 WO2004016605A1 (en) 2002-08-19 2003-08-14 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists
AU2003265170A AU2003265170A1 (en) 2002-08-19 2003-08-14 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists

Publications (1)

Publication Number Publication Date
AU2003265170A1 true AU2003265170A1 (en) 2004-03-03

Family

ID=34275461

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003265170A Abandoned AU2003265170A1 (en) 2002-08-19 2003-08-14 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists

Country Status (1)

Country Link
AU (1) AU2003265170A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275242B2 (en) * 2002-09-27 2010-03-04 Merck Sharp & Dohme Corp. Substituted pyrimidines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275242B2 (en) * 2002-09-27 2010-03-04 Merck Sharp & Dohme Corp. Substituted pyrimidines

Similar Documents

Publication Publication Date Title
AU5316000A (en) Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
AU2003242252A1 (en) Bicyclic pyrimidine derivatives
SI1487805T1 (en) Pyrimidine derivatives
IL161716A0 (en) ADENOSINE A2a RECEPTOR ANTAGONISTS
HUP0401925A3 (en) A2b adenosine receptor antagonists
IL158214A0 (en) 8-heteroaryl xanthine adenosine a2b receptor antagonists
IL161572A0 (en) Adenosine a2a receptor antagonists
IL152726A0 (en) Adenosine a2a receptor antagonists
AU5640199A (en) 4-quinolinemethanol derivatives as purine receptor antagonists (i)
AU2003281477A1 (en) 4-amino-substituted pyrimidine derivatives
TWI365879B (en) A2b adenosine receptor antagonists
IL174771A0 (en) Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
HUP0402324A3 (en) [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine derivatives as adenosine a2a receptor antagonists and pharmaceutical compositions containing them
AU2003231805A1 (en) Purine derivatives as liver x receptor agonists
AU2003301589A1 (en) Purine nucleosides
AU2003211993A1 (en) (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES
AU2002356369A1 (en) Xanthine derivatives as muscarinic receptor antagonists
PL370565A1 (en) 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
AU2003296601A1 (en) Antiviral nucleoside derivatives
AU2003290816A1 (en) Modified nucleosides as antiviral agents
AU2003265170A1 (en) 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists
AU2002368112A1 (en) Pyrimidine derivatives
HK1094192A (en) Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
HK1087706A (en) Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagonists
AU2002320199A1 (en) Purine derivatives as a2b adenosine receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase